Carregant...
New diarylsulfonamide inhibitors of Leishmania infantum amastigotes
New drugs against visceral leishmaniasis with mechanisms of action differing from existing treatments and with adequate cost, stability, and properties are urgently needed. No antitubulin drug is currently in the clinic against Leishmania infantum, the causative agent of visceral leishmaniasis in th...
Guardat en:
| Publicat a: | Int J Parasitol Drugs Drug Resist |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8142021/ https://ncbi.nlm.nih.gov/pubmed/34015753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2021.02.006 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|